期刊文献+

术中膀胱黏膜下注射盐酸氮芥、术后即刻丝裂霉素灌注化疗预防膀胱癌复发 被引量:3

The Prevention of Recurrence of Bladder Cancer by Intraoperative Bladder Submucosal Injection of Hydrochloric Acid Nitrogen Mustard and Postoperative Immediate Mitomycin Infusion of Transurethral Resection of the Bladder Tumor
下载PDF
导出
摘要 目的探讨经尿道膀胱肿瘤电切(TUR-Bt)术中膀胱黏膜下注射盐酸氮芥、术后即刻丝裂霉素(MMC)膀胱灌注化疗预防膀胱癌复发的疗效。方法 112例行TUR-Bt术的膀胱癌患者随机分为2组,对照组56例:行TUR-Bt术后1周给予MMC常规膀胱灌注化疗;治疗组56例:TUR-Bt术中经尿道行膀胱黏膜下注射盐酸氮芥,术后再即刻行MMC膀胱灌注化疗,术后1周再给予MMC常规膀胱灌注化疗。比较观察2组患者术后3、6、12、18、24个月的复发情况。结果治疗组术后3、6、12、18、24个月的复发率低于对照组,比较差异有统计学意义(P<0.05)。结论 TUR-Bt术中膀胱黏膜下注射盐酸氮芥、术后即刻行MMC膀胱灌注化疗能显著提高膀胱癌治疗效果,减少术后复发,且无明显毒副反应。 Objective To investigate the preventive efficacy of intraoperative bladder submucosal injection of hydrochloric acid nitrogen mustard and postoperative immediate mitomycin (MMC) infusion for the recurrence of bladder cancer in the transurethral resection of the bladder tumor (TUR-Bt). Methods All the 112 patients with blad- der cancer treated with TUR-Bt were randomly divided into two groups: the 56 cases in the control group received the MMC conventional bladder infusion; the other 56 cases in the treatment group were treated with intraoperative bladder submucosal injection of hydrochloric acid nitrogen mustard and postoperative immediate MMC infusion,and received the MMC conventional bladder infusion one week after the TUR-Bt. The recurrence of bladder cancer of the two groups in the 3,6,12,18,24 months after the TUR-Bt were analyzed comparatively. Results In the 3,6,12, 18,24 months after the TUR-Bt,the postoperative recurrence rates of the treatment group were higher than those of the control group,there was a significant difference ( P 〈 0.05). Conclusion In the TUR-Bt,intraoperative bladder submucosal injection of hydrochloric acid nitrogen mustard and postoperative immediate MMC iutusion can significantly improve the treatment efficacy of bladder cancer, reduce the recurrence,and the toxicities are tolerated.
出处 《肿瘤基础与临床》 2012年第3期246-248,共3页 journal of basic and clinical oncology
关键词 膀胱癌 盐酸氮芥 黏膜下注射 经尿道膀胱肿瘤电切术 丝裂霉素 bladder cancer hydrochloric acid nitrogen mustard submucosal injection transurethral resection of the bladder tumor mitomycin
  • 相关文献

参考文献7

二级参考文献19

  • 1吴荣扬,彭善友.膀胱粘膜下注射抗癌药物的实验研究与临床观察[J].中华泌尿外科杂志,1993,14(2):108-110. 被引量:40
  • 2[6]Lamm D L. Prophylaxis for recurrent transitional cell carcinoma [J]. Urology, 1991,31(Supp15):21 ~25
  • 3[1]Lamm DL.Long-term results of intravesical therapy for superficial bladder cancer[J].Urol Clin North Am,1992,19(1) :573 - 580.
  • 4[5]Akaza H,Niijima T,Hisamatsu T,et al.Comparative investigation on use of (2″R)-4′-O-tetrahydropyranyl-adriamycin and adriamycin as intravesical chemotherapy for superficial bladder tumors[J].J Urol,1998,32(2) :141 - 145.
  • 5[6]Yamamoto Y,Nasu Y,Saika T,et al.The absorption of pirarubicin instilled intravesically immediately after transurethral resection of superficial bladder cancer[J].BJU Int,2000,86(7) :802 - 804.
  • 6Abeloff MD,Armitage JO,Lichter AS.Clinical Oncology[M].Peking:Scientific Publishing Agency,2001.1801.
  • 7Timberg G,Rahu M,Gornoi K,et al. Bladder cancer in Estonia, 1968 ~1992:incidence,mortality,prevalence and survival[J].Scand J Urol Nephrol, 1997,31(4):357-342.
  • 8Thorn M, Bergstrom R, Johansson AM,et al. Trends in urinary bladder cancer incidence in Sweden 1960~1993with special reference to histopathology,time period,birth cohort,and smoking[J]. Cancer Causes Control, 1997,8(4):560-567.
  • 9Uemura H.Internal image anti-idiotype antibodies related to renal-cell carcinoma-associated antigen[J].G250,1994,56:608-614.
  • 10凌莉,方积乾.肿瘤发病和死亡资料的时间趋势分析[J].中国肿瘤,2001,10(1):24-26. 被引量:71

共引文献136

同被引文献27

  • 1Horstmann M,Witthuhn R,Falk M,et al.Gender-specific differences in bladder cancer:a retrospective analysis[J] .Gend Med,2008,5 (4):385-394.
  • 2Eble JN,Sauter G,Epstein JI.World Health Organization classification of tumours of the urinary system and male genital organs[M] .Lyon:IARC Press,2004.99-132.
  • 3Brennan P,Bogillot O,Cordier S.Cigarette smoking and bladder cancer in men:a pooled analysis of 11 case-control studies[J] .Int J Cancer,2000,86(2):289-294.
  • 4Samanic C,Kogevinas M,Dpsemeci M.Smoking and bladder cancer in Spain:effects of tobacco type,timing,environmental tobacco smoke,and gender[J] .Cancer Epid Biom Prev,2006,15(7):1348-1354.
  • 5Kogevinas M,Mannetje A,Cordier S.Occupation and bladder cancer among men in Western Europe[J] .Cancer Causes Control,2003,14 (10):907-914.
  • 6Olfert SM,Felknor SA,Delclos GL.An updated review of the literature:risk factors for bladder cancer with focus on occupational exposures[J] .South Med J,2006,99 (11):1256-1263.
  • 7Hayne D,Arya M,Quinn MLJ,et al.Current trends in bladder cancer in England and Wales[J] .J Urol,2004,172(3):1051-1055.
  • 8McGrath M,Michaud DS,De Vivo L.Hormonal and reproductive factors and the risk of bladder cancer in women[J] .Am J Epidemiol,2006,163 (3):236-244.
  • 9Madeb R,Messing EM.Gender,racial and age differences in bladder cancer incidence and mortality[J] .Urol Oncol,2004,22(2):86-92.
  • 10Hara I,Miyake H,Takechi Y.Clinical outcome of conservative therapy for stage T1,grade 3 transitional cell carcinoma of the bladder[J] .Int J Urol,2003,10(1):19-24.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部